Jan 22, 2026
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- Feb 6, 2026
Congress ticker disclosure profile
As of August 4 at 9:02 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference FERG. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
29
Member filers
6
Disclosed ranges
$130K
Most active member desks
17 buys vs 12 sells
Latest trade Jan 22, 2026
Jan 22, 2026
Ro KhannaJan 21, 2026
Ro KhannaDec 12, 2025
Richard W. AllenNov 20, 2025
Ro KhannaOct 27, 2025
Ro KhannaSep 23, 2025
Valerie HoyleJul 25, 2025
Ro KhannaJul 9, 2025
Ro KhannaJun 27, 2025
Ro KhannaApr 14, 2025
Gilbert CisnerosMar 17, 2025
Gilbert CisnerosMar 12, 2025
Ro KhannaMar 10, 2025
Ro KhannaJan 7, 2025
Gilbert CisnerosOct 9, 2024
Ro KhannaJul 2, 2024
Ro KhannaMay 3, 2024
Ro KhannaNov 3, 2023
Ro KhannaOct 31, 2023
Ro KhannaOct 20, 2023
Ro KhannaSep 13, 2023
Ro KhannaJul 12, 2023
Daniel GoldmanJul 10, 2023
Daniel GoldmanApr 26, 2023
Ro KhannaApr 17, 2023
Ro KhannaApr 14, 2023
Ro KhannaSep 2, 2022
Michael T. McCaulJun 29, 2022
Michael T. McCaulApr 21, 2022
Michael T. McCaul| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jan 22, 2026 | Ro Khanna | Sell | Receipt pending ingestion | Feb 6, 2026 | Open card |
| Jan 21, 2026 | Ro Khanna | Sell | Receipt pending ingestion | Feb 6, 2026 | Open card |
| Dec 12, 2025 | Richard W. Allen | Buy | $15,001 to $50,000 | Jan 15, 2026 | Open card |
| Nov 20, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Dec 8, 2025 | Open card |
| Oct 27, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Nov 6, 2025 | Open card |
| Sep 23, 2025 | Valerie Hoyle | Sell | $1,001 to $15,000 | Oct 10, 2025 | Open card |
| Jul 25, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Aug 7, 2025 | Open card |
| Jul 9, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Aug 7, 2025 | Open card |
| Jun 27, 2025 | Ro Khanna | Sell | Receipt pending ingestion | Jul 9, 2025 | Open card |
| Apr 14, 2025 | Gilbert Cisneros | Buy | $1,001 to $15,000 | May 6, 2025 | Open card |
| Mar 17, 2025 | Gilbert Cisneros | Buy | $15,001 to $50,000 | Apr 7, 2025 | Open card |
| Mar 12, 2025 | Ro Khanna | Buy | Receipt pending ingestion | Apr 10, 2025 | Open card |
| Mar 10, 2025 | Ro Khanna | Buy | Receipt pending ingestion | Apr 10, 2025 | Open card |
| Jan 7, 2025 | Gilbert Cisneros | Buy | $1,001 to $15,000 | Feb 11, 2025 | Open card |
| Oct 9, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Nov 8, 2024 | Open card |
| Jul 2, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Aug 7, 2024 | Open card |
| May 3, 2024 | Ro Khanna | Sell | Receipt pending ingestion | Jun 5, 2024 | Open card |
| Nov 3, 2023 | Ro Khanna | Buy | Receipt pending ingestion | Dec 6, 2023 | Open card |
| Oct 31, 2023 | Ro Khanna | Buy | Receipt pending ingestion | Nov 8, 2023 | Open card |
| Oct 20, 2023 | Ro Khanna | Buy | Receipt pending ingestion | Nov 8, 2023 | Open card |
| Sep 13, 2023 | Ro Khanna | Buy | Receipt pending ingestion | Oct 6, 2023 | Open card |
| Jul 12, 2023 | Daniel Goldman | Sell | $1,001 to $15,000 | Aug 13, 2023 | Open card |
| Jul 10, 2023 | Daniel Goldman | Sell | $15,001 to $50,000 | Aug 13, 2023 | Open card |
| Apr 26, 2023 | Ro Khanna | Buy | Receipt pending ingestion | May 8, 2023 | Open card |
| Apr 17, 2023 | Ro Khanna | Buy | Receipt pending ingestion | May 8, 2023 | Open card |
| Apr 14, 2023 | Ro Khanna | Buy | Receipt pending ingestion | May 8, 2023 | Open card |
| Sep 2, 2022 | Michael T. McCaul | Sell | Receipt pending ingestion | Oct 13, 2022 | Open card |
| Jun 29, 2022 | Michael T. McCaul | Buy | Receipt pending ingestion | Jul 20, 2022 | Open card |
| Apr 21, 2022 | Michael T. McCaul | Buy | Receipt pending ingestion | May 25, 2022 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 7 of 29 filed rows include disclosed amount ranges (24%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.